Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Net Margin
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | CN |
| Market Cap | 27.5B CNY |
| Net Margin |
12%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Net Margin |
-79%
|
| Country | US |
| Market Cap | 731.8B USD |
| Net Margin |
17%
|
| Country | DK |
| Market Cap | 4T DKK |
| Net Margin |
37%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Net Margin |
-4%
|
| Country | US |
| Market Cap | 372.2B USD |
| Net Margin |
45%
|
| Country | US |
| Market Cap | 332.3B USD |
| Net Margin |
4%
|
| Country | UK |
| Market Cap | 187.7B GBP |
| Net Margin |
13%
|
| Country | CH |
| Market Cap | 189B CHF |
| Net Margin |
20%
|
| Country | CH |
| Market Cap | 182.7B CHF |
| Net Margin |
30%
|
| Country | US |
| Market Cap | 161.7B USD |
| Net Margin |
-1%
|
Profitability Report
View the profitability report to see the full profitability analysis for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's most recent financial statements, the company has Net Margin of 11.9%.
You don't have any saved screeners yet
